Insider Transactions in Q1 2024 at Vor Biopharma Inc. (VOR)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,657
-1.53%
|
$25,314
$2.27 P/Share
|
|
Mar 01
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,576
-2.99%
|
$11,152
$2.27 P/Share
|
|
Mar 01
2024
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
6,310
-3.2%
|
$12,620
$2.27 P/Share
|
|
Feb 06
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,180
-1.03%
|
$2,360
$2.32 P/Share
|
|
Feb 06
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,033
-0.55%
|
$2,066
$2.32 P/Share
|
|
Feb 06
2024
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
985
-0.5%
|
$1,970
$2.32 P/Share
|
|
Feb 06
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,788
-0.34%
|
$5,576
$2.32 P/Share
|
|
Jan 29
2024
|
Robert Ang PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+15.29%
|
-
|
|
Jan 29
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
53,750
+22.26%
|
-
|
|
Jan 29
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+35.4%
|
-
|
|
Jan 29
2024
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+20.12%
|
-
|